[Response and survival after sequential chemotherapy in Hodgkin's disease].
D000477:Alkylating Agents / Q000008:administration & dosage; D001761:Bleomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D011344:Procarbazine / Q000008:administration & dosage; D012075:Remission, Spontaneous; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000477:Alkylating Agents; D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin
Risposta e sopravvivenza dopo chemiotherapia sequenziale nella malattia di Hodgkin.